MedPath

A cinical trial to study the effect of yoga intervention as well as standard treatment at genomic level in obese patients

Not Applicable
Conditions
Health Condition 1: null- Obese subjects with BMI 25-35 kg/m2Health Condition 2: E660- Obesity due to excess calories
Registration Number
CTRI/2016/08/007136
Lead Sponsor
AIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a.Adults aged between 20 and 45 years

b.Gender Both Male and Female

c.BMI - 25-35 kg/m2

Exclusion Criteria

a)Subjects enrolled in professional/supervised weight reduction program in last 12 months

b)Diabetic patients (Fasting plasma glucose > 126mg/dL)

c)Pregnant women

d)Subjects with inability or with restrictions to participate in a regular physical activity program

e)Subjects with any low grade chronic inflammatory diseases

f)Self- reported/previously diagnosed renal, hepatic & thyroid disorder

g)Subjects on vitamin D supplementation from last 3 months i.e 1000 IU

h)Subjects with heavy alcohol consumption ( >3 drinks/day) and smoking ( >2cigrettes/day)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To quantify the effect of yogaâ??based lifestyle intervention at genetic level by gene expression analysis of TNFα,IL-6, MRPL43, Nuclear factor Erythroid 2 (NFE2) as well as the telomere length and telomerase enzyme activity .Timepoint: 12 weeks
Secondary Outcome Measures
NameTimeMethod
�Changes in the Vitamin D receptor Gene expression after Yoga based lifestyle intervention <br/ ><br>�Quantification of protein level of TNFα, IL-6, MRPL43, Nuclear factor Erythroid 2 (NFE2. <br/ ><br>Timepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath